Capstone Investment Advisors’s Arcutis Biotherapeutics ARQT Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-57,378	Closed	-$569K	–	1050
2024 Q1	$569K	Buy	+57,378	New	+$569K	﹤0.01%	783
2023 Q4	–	Sell	-20,198	Closed	-$107K	–	1080
2023 Q3	$107K	Buy	+20,198	New	+$107K	﹤0.01%	1020